EA201791946A1 - Лечение хронической реакции "трансплантат против хозяина" с применением ингибиторов syk - Google Patents

Лечение хронической реакции "трансплантат против хозяина" с применением ингибиторов syk

Info

Publication number
EA201791946A1
EA201791946A1 EA201791946A EA201791946A EA201791946A1 EA 201791946 A1 EA201791946 A1 EA 201791946A1 EA 201791946 A EA201791946 A EA 201791946A EA 201791946 A EA201791946 A EA 201791946A EA 201791946 A1 EA201791946 A1 EA 201791946A1
Authority
EA
Eurasian Patent Office
Prior art keywords
transplantate
owner
treatment
syk inhibitors
versus host
Prior art date
Application number
EA201791946A
Other languages
English (en)
Inventor
Джули А. Ди Паоло
Джозеф Хау-Линг Лин
Шао-Ли Лин
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Publication of EA201791946A1 publication Critical patent/EA201791946A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В настоящем описании предложены способы применения соединений, ингибирующих тирозинкиназу селезенки (Syk), для лечения реакции "трансплантат против хозяина" (РТПХ) у человека, включая острую реакцию "трансплантат против хозяина" (оРТПХ) и хроническую реакцию "трансплантат против хозяина" (хРТПХ), включающие применение соединений, выбранных из группы, состоящих из соединений формул, приведенных ниже:
EA201791946A 2015-04-21 2016-04-19 Лечение хронической реакции "трансплантат против хозяина" с применением ингибиторов syk EA201791946A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562150691P 2015-04-21 2015-04-21
PCT/US2016/028303 WO2016172117A1 (en) 2015-04-21 2016-04-19 Treatment of chronic graft versus host disease with syk inhibitors

Publications (1)

Publication Number Publication Date
EA201791946A1 true EA201791946A1 (ru) 2018-03-30

Family

ID=55854820

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791946A EA201791946A1 (ru) 2015-04-21 2016-04-19 Лечение хронической реакции "трансплантат против хозяина" с применением ингибиторов syk

Country Status (14)

Country Link
US (1) US20160375019A1 (ru)
EP (1) EP3285808A1 (ru)
JP (1) JP2018513173A (ru)
KR (1) KR20170137200A (ru)
CN (1) CN107530354A (ru)
AU (1) AU2016252387A1 (ru)
BR (1) BR112017022323A2 (ru)
CA (1) CA2983611A1 (ru)
EA (1) EA201791946A1 (ru)
HK (2) HK1244453A1 (ru)
MX (1) MX2017013496A (ru)
SG (1) SG11201708075RA (ru)
TW (1) TW201711685A (ru)
WO (1) WO2016172117A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102307581B (zh) 2008-12-08 2016-08-17 吉利德康涅狄格股份有限公司 咪唑并哌嗪syk抑制剂
NZ602362A (en) 2010-03-11 2014-11-28 Gilead Connecticut Inc Imidazopyridines syk inhibitors
PL3027618T3 (pl) 2013-07-30 2021-04-19 Kronos Bio, Inc. Polimorf inhibitorów syk
CA2919479C (en) 2013-07-31 2017-08-22 Gilead Sciences, Inc. Syk inhibitors
US9687492B2 (en) 2013-12-04 2017-06-27 Gilead Sciences, Inc. Methods for treating cancers
TWI735853B (zh) 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
EA201790086A1 (ru) 2014-07-14 2017-07-31 Джилид Сайэнс, Инк. Комбинации для лечения раковых заболеваний
WO2017106564A1 (en) * 2015-12-17 2017-06-22 Gilead Sciences, Inc. Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders
EP3512519A1 (en) 2016-09-14 2019-07-24 Gilead Sciences, Inc. Syk inhibitors
EP3583128A1 (en) * 2017-02-17 2019-12-25 OSE Immunotherapeutics New uses of anti-sirpg antibodies
US11384082B2 (en) 2017-08-25 2022-07-12 Kronos Bio, Inc. Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors
WO2020015615A1 (zh) 2018-07-17 2020-01-23 深圳市塔吉瑞生物医药有限公司 用于抑制蛋白激酶活性的炔基（杂）芳环类化合物
KR20210131372A (ko) 2019-02-22 2021-11-02 크로노스 바이오, 인코포레이티드 Syk 억제제로서의 축합된 피라진의 고체 형태
CN112939983A (zh) * 2021-02-01 2021-06-11 暨明医药科技（苏州）有限公司 一种SYK激酶抑制剂Lanraplenib的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037900B2 (en) * 2001-10-12 2006-05-02 Supergen, Inc. Composition and method for treating graft-versus-host disease
US8450321B2 (en) * 2008-12-08 2013-05-28 Gilead Connecticut, Inc. 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
MX2011006091A (es) 2008-12-08 2011-11-29 Gilead Connecticut Inc Inhibidores de imidazopirazina syk.
KR20160036590A (ko) 2013-07-30 2016-04-04 질레드 코네티컷 인코포레이티드 Ｓｙｋ 억제제의 제제
PL3027618T3 (pl) 2013-07-30 2021-04-19 Kronos Bio, Inc. Polimorf inhibitorów syk
US9687492B2 (en) * 2013-12-04 2017-06-27 Gilead Sciences, Inc. Methods for treating cancers
TWI735853B (zh) * 2013-12-23 2021-08-11 美商克洛諾斯生技有限公司 脾酪胺酸激酶抑制劑
US9290505B2 (en) 2013-12-23 2016-03-22 Gilead Sciences, Inc. Substituted imidazo[1,2-a]pyrazines as Syk inhibitors

Also Published As

Publication number Publication date
HK1249054A1 (zh) 2018-10-26
WO2016172117A1 (en) 2016-10-27
CA2983611A1 (en) 2016-10-27
US20160375019A1 (en) 2016-12-29
KR20170137200A (ko) 2017-12-12
CN107530354A (zh) 2018-01-02
HK1244453A1 (zh) 2018-08-10
SG11201708075RA (en) 2017-11-29
AU2016252387A1 (en) 2017-10-19
TW201711685A (zh) 2017-04-01
EP3285808A1 (en) 2018-02-28
MX2017013496A (es) 2018-02-09
BR112017022323A2 (pt) 2018-07-03
JP2018513173A (ja) 2018-05-24

Similar Documents

Publication Publication Date Title
EA201791946A1 (ru) Лечение хронической реакции "трансплантат против хозяина" с применением ингибиторов syk
EA201891268A1 (ru) Соединения, которые можно применять в качестве ингибиторов киназы
EA201792529A1 (ru) Ингибиторы тирозинкиназы
EA202092590A1 (ru) Пиридазиноны в качестве ингибиторов parp7
EA201890730A1 (ru) Производные пиразолопиримидина в качестве ингибиторов btk для лечения злокачественного новообразования
MX2020012165A (es) Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer.
ZA201903932B (en) Imidazopyrazine inhibitors of bruton's tyrosine kinase
EA200901144A1 (ru) Ингибиторы киназы pim и способы их применения
PH12016501107B1 (en) Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
SG10201907819WA (en) N-((het)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors,
EA201690502A1 (ru) Замещенные пиримидиновые ингибиторы bmi-1
EA201792619A1 (ru) Нафтиридиновые соединения в качестве ингибиторов jak киназы
MX2021015826A (es) Metodos para tratar cancer usando compuestos de pirimidina y piridina con actividad inhibidora de tirosina cinasa de bruton.
MX367918B (es) Compuestos heterociclicos fusionados como inhibidores de proteina quinasa.
EA201790951A1 (ru) Производные гидроксиалкилзамещенного фенилтриазола и их применение
EA201100427A1 (ru) Гетероциклические ингибиторы киназы
EA201000094A1 (ru) Производные пиримидинил-пиридазинона
EA201690746A1 (ru) Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии
EA201890142A1 (ru) Замещенные пиримидиновые обратные ингибиторы bmi-1
MX2015011097A (es) Inhibidores de histona desmetilasas.
EA201100425A1 (ru) Производные пиколинамида в качестве ингибиторов киназы
MX2017004128A (es) Derivados de diarilurea como inhibidores de quinasa p38.
EA201690745A1 (ru) Способы лечения и предотвращения болезни "трансплантат против хозяина"
EA201792304A1 (ru) Комбинированная терапия для лечения рака
EA201100334A1 (ru) Бициклические производные триазола для лечения опухолей